Madam Therapeutics closes first financing round to develop novel antibiotics against drug resistant bacteria

August 27, 2018
Madam Therapeutics BV

Madam Therapeutics, a privately-held biotech company that is developing a novel class of antibiotics inspired by the defense mechanisms of the human body, today announced the closing of its first financing round of 1,1M EUR. 

More info on: https://www.madam-therapeutics.com/index.php/2018/08/27/madam-therapeutics-closes-first-financing-round-to-develop-novel-antibiotics-against-drug-resistant-bacteria/